Consecutive complex percutaneous coronary interventions using emicizumab and recombinant activated factor VII in a patient with severe haemophilia A and high-titre inhibitor

Affiliations

• ¹ Cardiovascular Center, Taichung Veterans General Hospital, Taichung, Taiwan.
• ² Division of Cardiology, Department of Internal Medicine, Kuang-Tien General Hospital, Taichung, Taiwan.
• ³ Center for Rare Disease and Hemophilia, Taichung Veterans General Hospital, Taichung, Taiwan.
• ⁴ Children's Medical Center, Taichung Veterans General Hospital, Taichung, Taiwan.
• ⁵ Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
• ⁶ Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
• ⁷ Department of Industrial Engineering and Enterprise Information, Tunghai University, Taichung, Taiwan.